Identifying which patients with metastatic hormone-sensitive prostate cancer benefit most from androgen receptor pathway inhibitors: STOPCAP systematic review and meta-analysis of individual participant data
Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Authors: Fisher, David, Rydzewska, Larysa H, Godolphin, Peter J, Vale, Claire L, Burdett, Sarah, Agarwal, Neeraj, Attard, Gert, Chi, Kim N, Clarke, Noel W, Davis, Ian D, Fizazi, Karim, Foulon, Stéphanie, Gillessen, Silke, James, Nicholas D, Matheson, David, Murphy, Laura, Oldroyd, Robert E, Parmar, Mahesh KB, Subhash, Vinod V, Sweeney, Christopher J, Tangen, Catherine M, Tombal, Bertrand F, White, Ian R, Tierney, Jayne F
Institutions: MRC Clinical Trials Unit at UCL, University College London, Huntsman Cancer Institute, Eastern Health, Centre Oscar Lambret, Institut Gustave Roussy, Institute of Oncology Research, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Università della Svizzera italiana, University of Wolverhampton, Breast Cancer Trials, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Ecogenomics (Japan), The University of Adelaide, Cliniques Universitaires Saint-Luc
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7220010108
FWCI:
Cites:
Cited by:
Related to: